Redbiotec is pleased to announce that it has entered into a collaboration with 4-Antibody, in which Redbiotec will apply its proprietary technology platform rePAX® to an undisclosed discovery area. This agreement is a further validation of the application of Redbiotec’s VLPs in antibody generation.
